U.S. Federal agencies have been prohibited from using public funds to cover gender transition treatments for minors from low-income families, effective October. The policy, announced by the administration, blocks coverage for procedures such as hormone therapy and surgeries. The decision has sparked immediate backlash from Democratic lawmakers, who argue it represents an overreach of executive power. Several members of Congress have vowed to challenge the policy in court, claiming it violates constitutional rights and disproportionately affects vulnerable populations.

The restriction applies to all federal programs that receive taxpayer money, including Medicaid and other health initiatives. Advocacy groups have expressed concern over the impact on transgender youth, emphasizing the importance of access to gender-affirming care. Legal challenges are expected to focus on the constitutionality of the policy and its potential to harm public health. The administration has defended the move as a necessary step to ensure responsible use of taxpayer resources.

The debate highlights growing tensions between federal agencies and lawmakers over healthcare policy. With the legal battle ongoing, the policy's future remains uncertain. The situation continues to draw national attention, with calls for both legislative action and judicial review.